About Cartilix
Cartilix is a Healthcare company based in Foster City (United States) founded in 2004, and was acquired by Biomet in October 2009. Cartilage regeneration technologies for knee repair are developed by Cartilix. Cartilix has raised $6.5 million across 2 funding rounds from investors including Biomet and De Novo Ventures. The company was acqui-hired. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Theradaptive, MiMedx Group and RevBio; 2 of its 3 listed competitors have raised funding.
Company details
Cartilix was founded in 2004 in Foster City, United States, within the biotechnology sector focused on orthopedic solutions. Operations centered on advancing cartilage repair through ChonDux, a technology that employs a biological adhesive and hydrogel to address articular cartilage lesions in knees. The company was acquired by Biomet in 2009 for an undisclosed sum, concluding its independent activities.
- Headquarters Foster City, United States
- Stage Acquired
- SectorsHealthcare
- Website cartilix.com
- Acquired by Biomet (Oct 2009)
Funding Insights of Cartilix
Cartilix has successfully raised a total of $6.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.5 million completed in June 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.5M
- Total Rounds 2
- Last Round Series A — $6.5M
- First Round $150,000
(Sep 2004)
- Investors Count 1
All 2 funding rounds of Cartilix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2006 | $6.5M | Series A | – | – | |
| Sep 2004 | $150,000 | Debt – Convertible | – | – | – |
2 investors in total: 2 institutional.
Investors in Cartilix
Cartilix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Biomet and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| denovovc.com | ||||
Orthopedic surgical and non-surgical products are designed and distributed. | 1977 | biomet.com | Warsaw, United States |
Investor details for Cartilix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cartilix
4 dated milestones of Cartilix across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cartilix is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series A, of $6.5M.
- Exit Acquired by Biomet.
Competitors of Cartilix
Cartilix has 3 listed competitors in our database, 2 of them funded. They include Theradaptive, MiMedx Group and RevBio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. | |
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | ||
| revbio.com | 2014 | Lowell, United States | $24.42M | Synthetic adhesives for bone and dental repair are developed. |
Detailed competitors of Cartilix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Cartilix (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cartilix
Cartilix was founded in 2004.
Cartilix is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
Cartilix is a funded company, having raised a total of $6.5M across 2 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $150K, raised on Sep 2004.
Cartilix was founded in 2004 in Foster City, United States, within the biotechnology sector focused on orthopedic solutions. Operations centered on advancing cartilage repair through ChonDux, a technology that employs a biological adhesive and hydrogel to address articular cartilage lesions in knees. The company was acquired by Biomet in 2009 for an undisclosed sum, concluding its independent activities.
Cartilix's top competitors include Theradaptive, MiMedx Group and RevBio.
Cartilix has 2 investors. Key investors include Biomet, and De Novo Ventures.
Yes. Cartilix was acquired by Biomet in October 2009.